Original language | English |
---|---|
Pages (from-to) | S53-S54 |
Number of pages | 2 |
Journal | European Journal of Cancer |
Volume | 51 |
DOIs | |
Publication status | Published - Sept 2015 |
300 Phase I study of two dosing schedules of the investigational oral pan-RAF kinase inhibitor MLN2480 in patients (pts) with advanced solid tumors or melanoma
D.W. Rasco, M.R. Middleton, R. Gonzalez, P. Corrie, A. Pavlick, P. Lorigan, R. Plummer, M. Gore, C. Herbert, S.S. Agarwala, T.F. Logan, S.N. Khleif, K.P. Papadopoulos, L. Rangachari, A. Suri, Q. Xu, M. Kneissl, V. Bozón, A.J. Olszanski
Research output: Contribution to journal › Article › peer-review